CellR4 2023; 11: e3419
DOI: 10.32113/cellr4_202312_3419

Investigation of the effects of B16F10 derived exosomes in induction of immunosuppressive phenotype in the hematopoietic stem cells

CellR4 2023; 11: e3411
DOI: 10.32113/cellr4_20239_3411

Clinical trials of cellular therapies for the treatment of colorectal cancer: a narrative review

CellR4 2022; 10: e3332
DOI: 10.32113/cellr4_202210_3332

Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study

CellR4 2022; 10: e3330
DOI: 10.32113/cellr4_202210_3330

Corrigendum – Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

CellR4 2022; 10: e3322
DOI: 10.32113/cellr4_20228_3322

The cellular markers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune response

CellR4 2022; 10: e3289
DOI: 10.32113/cellr4_20223_3289

Decreased Treg/Th17 ratio in Bulgarian patients after liver transplantation: a single-center experience

CellR4 2021; 9: e3280
DOI: 10.32113/cellr4_202112_3280

Intravenous SONG-modulated laser-activated allogeneic cord blood mesenchymal stem cells for the treatment of end-stage heart failure: a preliminary clinical study